Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

How I manage pulmonary Langerhans cell histiocytosis.

European respiratory review : an official journal of the European Respiratory Society - 30 Sept 2017

Lorillon Gwenaël, Tazi Abdellatif

Abstract excerpt

Pulmonary Langerhans cell histiocytosis (PLCH) is a rare sporadic cystic lung disease of unknown aetiology that is characterised by the infiltration and destruction of the wall of distal bronchioles by CD1a+ Langerhans-like cells. In adults, PLCH is frequently isolated and affects young smokers of both sexes. Recent multicentre studies have led to the more standardised management of patients in clinical practice....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Mutation
Share to Phenotype
Share to BRAF gene

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Immunosuppressive Agents

Share to Protein Kinase Inhibitors

Share to Proto-Oncogene Proteins B-raf

Source

Open in PubMed Open full text

Identifiers

PMID: 28877978
DOI: 10.1183/16000617.0070-2017
PMCID: PMC9489169

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

How I manage pulmonary Langerhans cell histiocytosis.PMID 28877978Read ↗

Current understanding and management of pulmonary Langerhans cell histiocytosis.Semantic proximity Read ↗

Pulmonary Langerhans cell histiocytosis – an update on pathogenesis and treatmentSemantic proximity Read ↗

Pulmonary Langerhans Cell Histiocytosis: An Update From the Pathologists' Perspective.Semantic proximity Read ↗

International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults.Semantic proximity Read ↗

Langerhans Cell Histiocytosis and Other Histiocytic Diseases of the Lung.Semantic proximity Read ↗

Pulmonary Langerhans Cell Histiocytosis.Semantic proximity Read ↗

Pulmonary langerhans cell histiocytosisSemantic proximity Read ↗

Clinical features and treatment of Langerhans cell histiocytosis.Semantic proximity Read ↗

Recent advances in the management of lymphangioleiomyomatosisSemantic proximity Read ↗

How I manage patients with hairy cell leukaemia.Semantic proximity Read ↗

Lung structure disorders visualized by chest computed tomography in patients with pulmonary Langerhans cell histiocytosis and their correlation with the pulmonary function tests and disease extensionSemantic proximity Read ↗

Lung Transplant in a Patient With Multifocal Langerhans Cell Histiocytosis After Chemotherapy With Cladribine: A Case Report.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.